Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10.2M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
104K
-
Shares change
-
-94.6K
-
Total reported value, excl. options
-
$291K
-
Value change
-
+$210K
-
Number of buys
-
23
-
Number of sells
-
-5
-
Price
-
$2.79
Significant Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) as of Q1 2025
31 filings reported holding BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 104K shares
of 10.2M outstanding shares and own 1.02% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (50K shares), GEODE CAPITAL MANAGEMENT, LLC (15.5K shares), MORGAN STANLEY (12K shares), BlackRock, Inc. (10.1K shares), BANK OF AMERICA CORP /DE/ (8.39K shares), OSAIC HOLDINGS, INC. (3.21K shares), UBS Group AG (2.37K shares), GROUP ONE TRADING LLC (1.79K shares), SBI Securities Co., Ltd. (262 shares), and COLDSTREAM CAPITAL MANAGEMENT INC (138 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.